The direct thrombin inhibitor melagatran/ximelagatran.
Bereznicki
Luke R
LR
Jackson
Shane L
SL
Peterson
Gregory M
GM
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications; D001384:Azetidines / Q000191:economics / Q000627:therapeutic use*; D001596:Benzylamines / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D012449:Safety; D013917:Thrombin / Q000037:antagonists & inhibitors*; D013923:Thromboembolism / Q000517:prevention & control; D014859:Warfarin / Q000191:economics / Q000627:therapeutic use
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C109573:melagatran; C426686:ximelagatran; D014859:Warfarin; D013917:Thrombin